Cargando…
Synthesis of 3-fluoro-6-S-(2-S-pyridyl) nucleosides as potential lead cytostatic agents
The 3-deoxy-3-fluoro-6-S-(2-S-pyridyl)-6-thio-β-d-glucopyranosyl nucleoside analogs 7 were prepared via two facile synthetic routes. Their precursors, 3-fluoro-6-thio-glucopyranosyl nucleosides 5a-e, were obtained by the sequence of deacetylation of 3-deoxy-3-fluoro-β-d-glucopyranosyl nucleosides 2a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112006/ https://www.ncbi.nlm.nih.gov/pubmed/20817215 http://dx.doi.org/10.1016/j.bioorg.2010.08.001 |
_version_ | 1783513398020931584 |
---|---|
author | Tsoukala, Evangelia Tzioumaki, Niki Manta, Stella Riga, Alexandra Balzarini, Jan Komiotis, Dimitri |
author_facet | Tsoukala, Evangelia Tzioumaki, Niki Manta, Stella Riga, Alexandra Balzarini, Jan Komiotis, Dimitri |
author_sort | Tsoukala, Evangelia |
collection | PubMed |
description | The 3-deoxy-3-fluoro-6-S-(2-S-pyridyl)-6-thio-β-d-glucopyranosyl nucleoside analogs 7 were prepared via two facile synthetic routes. Their precursors, 3-fluoro-6-thio-glucopyranosyl nucleosides 5a-e, were obtained by the sequence of deacetylation of 3-deoxy-3-fluoro-β-d-glucopyranosyl nucleosides 2a-e, selective tosylation of the primary OH of 3 and finally treatment with potassium thioacetate. The desired thiolpyridine protected analogs 7a-c,f,g were obtained by the sequence of deacetylation of 5a-c followed by thiopyridinylation and/or condensation of the corresponding heterocyclic bases with the newly synthesized peracetylated 6-S-(2-S-pyridyl) sugar precursor 13, which was obtained via a novel synthetic route from glycosyl donor 12. None of the compounds 6 and 7 showed antiviral activity, but the 5-fluorouracil derivative 7c and particularly the uracil derivative 7b were endowed with an interesting and selective cytostatic action against a variety of murine and human tumor cell cultures. |
format | Online Article Text |
id | pubmed-7112006 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71120062020-04-02 Synthesis of 3-fluoro-6-S-(2-S-pyridyl) nucleosides as potential lead cytostatic agents Tsoukala, Evangelia Tzioumaki, Niki Manta, Stella Riga, Alexandra Balzarini, Jan Komiotis, Dimitri Bioorg Chem Article The 3-deoxy-3-fluoro-6-S-(2-S-pyridyl)-6-thio-β-d-glucopyranosyl nucleoside analogs 7 were prepared via two facile synthetic routes. Their precursors, 3-fluoro-6-thio-glucopyranosyl nucleosides 5a-e, were obtained by the sequence of deacetylation of 3-deoxy-3-fluoro-β-d-glucopyranosyl nucleosides 2a-e, selective tosylation of the primary OH of 3 and finally treatment with potassium thioacetate. The desired thiolpyridine protected analogs 7a-c,f,g were obtained by the sequence of deacetylation of 5a-c followed by thiopyridinylation and/or condensation of the corresponding heterocyclic bases with the newly synthesized peracetylated 6-S-(2-S-pyridyl) sugar precursor 13, which was obtained via a novel synthetic route from glycosyl donor 12. None of the compounds 6 and 7 showed antiviral activity, but the 5-fluorouracil derivative 7c and particularly the uracil derivative 7b were endowed with an interesting and selective cytostatic action against a variety of murine and human tumor cell cultures. Elsevier Inc. 2010-12 2010-08-17 /pmc/articles/PMC7112006/ /pubmed/20817215 http://dx.doi.org/10.1016/j.bioorg.2010.08.001 Text en Copyright © 2010 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Tsoukala, Evangelia Tzioumaki, Niki Manta, Stella Riga, Alexandra Balzarini, Jan Komiotis, Dimitri Synthesis of 3-fluoro-6-S-(2-S-pyridyl) nucleosides as potential lead cytostatic agents |
title | Synthesis of 3-fluoro-6-S-(2-S-pyridyl) nucleosides as potential lead cytostatic agents |
title_full | Synthesis of 3-fluoro-6-S-(2-S-pyridyl) nucleosides as potential lead cytostatic agents |
title_fullStr | Synthesis of 3-fluoro-6-S-(2-S-pyridyl) nucleosides as potential lead cytostatic agents |
title_full_unstemmed | Synthesis of 3-fluoro-6-S-(2-S-pyridyl) nucleosides as potential lead cytostatic agents |
title_short | Synthesis of 3-fluoro-6-S-(2-S-pyridyl) nucleosides as potential lead cytostatic agents |
title_sort | synthesis of 3-fluoro-6-s-(2-s-pyridyl) nucleosides as potential lead cytostatic agents |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112006/ https://www.ncbi.nlm.nih.gov/pubmed/20817215 http://dx.doi.org/10.1016/j.bioorg.2010.08.001 |
work_keys_str_mv | AT tsoukalaevangelia synthesisof3fluoro6s2spyridylnucleosidesaspotentialleadcytostaticagents AT tzioumakiniki synthesisof3fluoro6s2spyridylnucleosidesaspotentialleadcytostaticagents AT mantastella synthesisof3fluoro6s2spyridylnucleosidesaspotentialleadcytostaticagents AT rigaalexandra synthesisof3fluoro6s2spyridylnucleosidesaspotentialleadcytostaticagents AT balzarinijan synthesisof3fluoro6s2spyridylnucleosidesaspotentialleadcytostaticagents AT komiotisdimitri synthesisof3fluoro6s2spyridylnucleosidesaspotentialleadcytostaticagents |